ArticlePharmacoEconomics2001

Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.

E S Dietrich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.